Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Top Cited Papers
Open Access
- 23 May 2008
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 21 (12) , 1451-1460
- https://doi.org/10.1038/modpathol.2008.96
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcomeBritish Journal of Cancer, 2007
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancerLaboratory Investigation, 2007
- Frequency of theTMPRSS2:ERGgene fusion is increased in moderate to poorly differentiated prostate cancersJournal of Clinical Pathology, 2007
- TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN LesionsNeoplasia, 2006
- Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with RearrangementNeoplasia, 2006
- Identification of a tumour suppressor network opposing nuclear Akt functionNature, 2006
- FISH Analysis for the Detection of Lymphoma-Associated Chromosomal Abnormalities in Routine Paraffin-Embedded TissueThe Journal of Molecular Diagnostics, 2006
- Loss of PTEN is associated with progression to androgen independenceThe Prostate, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005